+924.9%
MRNA vs VRSK
-2.2%
+927.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VRSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | +6.9% | -13.4% | -9.1% |
| 7D | +8.4% | +10.9% | -2.5% | +3.7% |
| 30D | +28.8% | +28.0% | +0.8% | +12.4% |
| 3M | +329.2% | +12.3% | +316.9% | +293.3% |
| 6M | +416.9% | +17.8% | +399.1% | +373.2% |
| YTD | +718.8% | -4.7% | +723.5% | +637.6% |
| 1Y | +924.9% | -0.2% | +925.1% | +816.0% |
| All | +924.9% | -2.2% | +927.1% | +816.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSK.
Daily Out/Under-Performance
Portfolio return minus VRSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VRSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling